Longevity
Investors
Conference

Save the date!

The next Longevity Investors Conference will be held in Gstaad on September 27-29 2023.

  • LinkedIn
  • Twitter
  • Instagram
  • Youtube

About the conference 

The Longevity Investors Conference is the most exclusive conference for longevity investors.

LIC provides relevant insights into the longevity subject, expert education, investment opportunities, excellent networking opportunities and a great setting in an exclusive location.

The two full days conference is bringing together the world’s top longevity KOLs, institutional and private investors, wealthy private investors, family offices and funds.

What is Longevity?

Longevity is the science of anti-aging research and rejuvenation.

 

It has experienced an unprecedented advance over recent years, particularly with the discovery that the rate of aging is controlled, at least to some extent, by genetic pathways and biochemical processes.

Longevity identifies both lifestyle and pharmaceutical targets to improve the human health-span (i.e.the time we can live without any negative impact from aging.)

Longevity will be one of the largest, if not the largest, investment opportunity in the decades to come.

 

Why join the LIC?

  • The number of participants is limited and curated to 150, ensuring high quality networking and community building in a unique setting. Investors can meet other investors as well as leading longevity experts and KOLs.

  • Get to know the industry inside and out from the best-in-field speakers.

  • Get acquainted with the latest and most attractive investment opportunities in the longevity field.

  • Establish strategic partnerships with other business leaders in one of a kind setting in 5*hotel in Gstaad, one of the most exclusive Swiss mountain resorts.

  • Get acquainted and experience with the latest trends related to personal longevity (supplements, therapies, and many more).

Screenshot 2022-02-17 at 17.59.25.png

Investors

Screenshot 2022-02-17 at 17.59.34.png

C-level Executives

Screenshot 2022-02-17 at 17.59.41.png

Academia

Screenshot 2022-02-17 at 17.58.35.png

30+

Outstanding Speakers

Screenshot 2022-02-17 at 17.58.42.png

100-150

Hand-picked delegates

Screenshot 2022-02-17 at 17.59.02.png

2 full-days

Conference

Packages

ACCOMMODATION AT BERNERHOF HOTEL

BERNERHOF HOTEL

Package with accommodation at the Bernerhof**** Hotel.

Price: SOLD OUT

Includes:

  • 2-nights stay at the Bernerhof Hotel

  • 2 breakfasts 

  • 2 lunches on Wednesday and Thursday 

  • Networking dinner on Wednesday evening 

  • Gala Dinner on Thursday evening 

  • Coffee breaks during the conference at Le Grand Bellevue

  • Transfer service during the conference days from Le Grand Bellevue to locations in Gstaad

  • Access to the LIC networking and matchmaking app

 

The package does NOT include:

  • Travel service to and from Gstaad

ACCOMMODATION AT ERMITAGE HOTEL

ERMITAGE HOTEL

Package with accommodation at the Ermitage***** Hotel.

Price:         SOLD OUT

Includes:

  • 2-nights stay at the Ermitage Hotel            

  • 2 breakfasts 

  • 2 lunches on Wednesday and Thursday 

  • Networking dinner on Wednesday evening

  • Gala Dinner on Thursday evening 

  • Coffee breaks during the conference at Le Grand Bellevue

  • Transfer service during the conference days from Le Grand Bellevue to locations in Gstaad

  • Access to the LIC networking and matchmaking app

 

The package does NOT include:

  • Travel service to and from Gstaad

CONFERENCE-ONLY

CONFERENCE ONLY

 

Package without accommodation

 

Price:         SOLD OUT

Includes:

​​​

  • 2 breakfasts 

  • 2 lunches on Wednesday and Thursday 

  • Networking "flying-dinner" on Wednesday evening 

  • Gala Dinner on Thursday evening 

  • Coffee breaks during the conference at Le Grand Bellevue

  • Transfer service during the conference days from Le Grand Bellevue to locations in Gstaad

  • Access to the LIC networking and matchmaking app

The package does NOT include:

  • Travel service to and from Gstaad

  • Accommodation

 

Speakers 

We had the honor of welcoming the leading longevity industry experts and scientists at the conference

GREG%20HUNG_edited.png
Bildschirmfoto 2021-05-05 um 18.02.35.pn
Bildschirmfoto 2021-05-05 um 18.02.16.pn

George Church

Professor of Genetics, Harvard Medical School

George is Professor of Genetics at Harvard Medical School and Professor of Health Sciences and Technology at Harvard and the Massachusetts Institute of Technology (MIT). He is Director of the U.S. Department of Energy Technology Center and Director of the National Institutes of Health Center of Excellence in Genomic Science. He has received numerous awards including the 2011 Bower Award and Prize for Achievement in Science from the Franklin Institute and election to the National Academy of Sciences and Engineering.

George leads Synthetic Biology at the Wyss Institute and is widely recognized for his innovative contributions to genomic science and his many pioneering contributions to chemistry and biomedicine. In 1984, he developed the first direct genomic sequencing method, which resulted in the first genome sequence (the human pathogen, H. pylori). He helped initiate the Human Genome Project in 1984 and the Personal Genome Project in 2005.

GREG%20HUNG_edited.png
Bildschirmfoto 2021-05-05 um 18.02.35.pn
Bildschirmfoto 2021-05-05 um 18.02.16.pn

Nir Barzilai

Director, Institute for Aging Research, Albert Einstein College of Medicine

Dr. Nir Barzilai serves as director of the Institute for Aging Research at the Albert Einstein College of Medicine. In addition, he is a founder and board member of CohBar Inc. Listed on the Russel 2000 Index, it develops therapeutics based on mitochondrial-derived peptides. He is a renowned expert and scientist in the study of the biology and genetics of aging.

He is also a founder and a Medical Consultant to Lifebiosciences, targeting therapeutics against the hallmark of aging. He is leading the TAME (Targeting Aging with MEtformin) multi-central study to show that aging can be a target in humans in support of changing the FDA indication that is relevant to targeting aging.

Dr. Barzilai is the recipient of many awards including the 2010 Irving S. Wright Award of Distinction in Aging Research and is the 2018 recipient of the IPSEN Longevity Award. His work has been profiled by outlets such as the New York Times, BBC, PBS, and National Geographic. He received his MD from Technion-Israel Institute of Technology.

GREG%20HUNG_edited.png
Bildschirmfoto 2021-05-05 um 18.02.35.pn
Bildschirmfoto 2021-05-05 um 18.02.16.pn

Aubrey de Grey

Dr. Aubrey de Grey is an English author and biomedical gerontologist. He is the author of The Mitochondrial Free Radical Theory of Aging and co-author of Ending Aging. His research interests encompass the characterisation of all the types of self-inflicted cellular and molecular damage that constitute mammalian aging and the design of interventions to repair and/or obviate that damage.

Dr. de Grey is a Fellow of both the Gerontological Society of America and the American Ageing Association, and sits on the editorial and scientific advisory boards of numerous journals and organisations. He is a highly sought-after speaker who gives talks at scientific conferences, universities, companies in areas ranging from pharma to life insurance, and to the public.